Article
Multidisciplinary Sciences
Yeliz Z. Akkaya-Ulum, Tayfun Hilmi Akbaba, Zeynep Tavukcuoglu, Jae Jin Chae, Engin Yilmaz, Seza Ozen, Banu Balci-Peynircioglu
Summary: Familial Mediterranean fever (FMF) is an autosomal recessively inherited autoinflammatory disease caused by mutations in the MEFV gene. Recent studies suggest that non-coding RNAs, particularly miRNAs, may play a role in the pathogenesis of autoinflammation. Research on miR-197-3p in FMF patients shows its potential anti-inflammatory effect, indicating a possible role in personalized medicine for autoinflammatory diseases.
SCIENTIFIC REPORTS
(2021)
Article
Rheumatology
Avishai M. Tsur, Abdulla Watad, Omer Gendelman, Daniel Nissan, Arnon D. Cohen, Howard Amital
Summary: The study found a positive association between FMF and asthma through a cross-sectional study. Further research is needed to validate and explore possible explanations for this association. These findings challenge previous studies that suggested FMF as a protective factor against asthma.
Article
Medicine, General & Internal
Joerg C. Henes, Sebastian Saur, David M. Kofler, Claudia Kedor, Christoph Meisner, Marion Schuett, Martin Krusche, Ina Koetter, Theodoros Xenitidis, Hendrik Schulze-Koops, Eugen Feist
Summary: This study evaluated the effectiveness and safety of the IL-6 receptor antibody Tocilizumab in treating Familial Mediterranean Fever. The results showed that more patients in the Tocilizumab group achieved an adequate treatment response compared to the placebo group. Tocilizumab also normalized the serum amyloid A levels, which is important in preventing amyloidosis. These findings need to be confirmed in a larger trial.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Medicine, General & Internal
Shuhei Yoshida, Yuya Sumichika, Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita
Summary: This study investigated the clinical features and treatment response of Japanese patients with FMF. It found that colchicine was effective in the majority of patients, but some patients showed resistance to colchicine. Canakinumab showed good efficacy in colchicine-resistant patients.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Oncology
Weiguo Ma, Ning Xue, Junhua Zhang, Dan Wang, Xiaobin Yao, Lin Lin, Qingxia Xu
Summary: The study showed that circular RNA-ubiquitin associated protein 2 is upregulated in osteosarcoma and regulates malignant behavior of osteosarcoma cells through the miR-204-3p/HMGA2 axis.
INTERNATIONAL JOURNAL OF ONCOLOGY
(2021)
Article
Pharmacology & Pharmacy
Francesca Marinelli, Chiara Caporilli, Annachiara Titolo, Donato Rigante, Susanna Esposito
Summary: This short review explores the overlap in the pathophysiology of familial Mediterranean fever (FMF) and SARS-CoV-2 infection, discussing the interaction between the two diseases and how to optimize management. It is observed that infected FMF patients do not seem to have a poorer outcome of SARS-CoV-2 infection. COVID-19 vaccines are recommended for these patients and their safety profile is expected to be similar to the general population.
PHARMACOLOGICAL RESEARCH
(2022)
Article
Biotechnology & Applied Microbiology
Wenyuan Tao, Linjie Yu, Shu Shu, Ying Liu, Zi Zhuang, Siyi Xu, Xinyu Bao, Yue Gu, Fang Cai, Weihong Song, Yun Xu, Xiaolei Zhu
Summary: The study showed that miR-204-3p attenuated memory deficits and oxidative stress in APP/PS1 mice by targeting Nox4, indicating that miR-204-3p overexpression and/or Nox4 inhibition could be a potential therapeutic strategy for AD treatment.
Review
Biochemistry & Molecular Biology
Maddalena Lancieri, Marta Bustaffa, Serena Palmeri, Ignazia Prigione, Federica Penco, Riccardo Papa, Stefano Volpi, Roberta Caorsi, Marco Gattorno
Summary: This study provides an updated overview on the main aspects of pathophysiology, genetics, diagnosis, and treatment resistance of Familial Mediterranean Fever (FMF), a prototypal autoinflammatory disease. It also emphasizes the importance of FMF in understanding the functioning of the innate immune system.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Endocrinology & Metabolism
Stefana Stojanovic, Zorana Dobrijevic, Sonja Selemetjev, Ilona Doric, Jelena Jankovic Miljus, Vladan Zivaljevic, Tijana Isic Dencic
Summary: The expression of miR-203a-3p, miR-204-3p, and miR-222-3p can assist in the differential diagnosis of thyroid neoplasias. Higher expression of miR-222-3p is associated with extrathyroid invasion and advanced stage of thyroid cancer, and can serve as a prognostic tool for personalized treatment.
Article
Cell Biology
Ling Yuan, Jiaxin Li, Yi Yang, Yan Chen, Yang Bu, Mengyi Ye, Xiongjie Mao, Tingting Ma, Lei Yu, Yi Nan
Summary: LINC00514 is upregulated in gastric cancer and promotes cell growth and EMT progression by binding to miR-204-3p. It also enhances KRAS expression, which is inhibited by miR-204-3p. Therefore, LINC00514 may act as an oncogene and therapeutic target in gastric cancer.
Review
Pharmacology & Pharmacy
Dimitri Poddighe, Micol Romano, Facundo Garcia-Bournissen, Erkan Demirkaya
Summary: Familial Mediterranean fever (FMF) is commonly diagnosed in childhood and is treated predominantly with colchicine, but in cases of intolerance or resistance, the use of biologics, especially interleukin-1 antagonists, should be considered.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
(2022)
Review
Rheumatology
Seza Ozen
Summary: Recent studies have revealed new insights into the pathogenesis of familial Mediterranean fever, including genetic mutations conferring resistance to ancient microbial pathogens and recommendations for genetic analysis of FMF. We now have recommendations for assessing genetic analysis of the MEFV gene and how to reliably classify a patient as FMF.
CURRENT OPINION IN RHEUMATOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Heyam Hayder, Guodong Fu, Lubna Nadeem, Jacob A. O'Brien, Stephen J. Lye, Chun Peng
Summary: The overexpression of miR-210-3p reduces trophoblast migration and invasion, affects EVT outgrowth in early pregnancy explants, and decreases the ability of trophoblast to form endothelial-like networks. Furthermore, miR-210-3p downregulates the expression of certain cytokines, potentially influencing EVT invasion and immune cell recruitment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Nutrition & Dietetics
Pasquale Mansueto, Aurelio Seidita, Marta Chiavetta, Dario Genovese, Alessandra Giuliano, Walter Priano, Antonio Carroccio, Alessandra Casuccio, Emanuele Amodio
Summary: This narrative review analyzed the correlation between diet and clinical outcomes of familial Mediterranean fever (FMF). Conflicting results were found regarding the association between high-fat and high-salt food intake and FMF attack recurrence. Wheat was suggested to potentially play a role in FMF. A diet rich in antioxidants and anti-inflammatory supplements may partly reduce symptoms and improve the well-being of FMF patients. However, further studies are needed to clarify the impact of diet on FMF symptom triggering.
Article
Biochemistry & Molecular Biology
Zeynep Tavukcuoglu, Yeliz Z. Akkaya-Ulum, Nilgun Yersal, Utku Horzum, Tayfun Hilmi Akbaba, Omer Karadag, Gunes Esendagli, Petek Korkusuz, Seza Ozen, Banu Balci-Peynircioglu
Summary: This study analyzed the presence of miRNAs in serum extracellular vesicles (EVs) of familial Mediterranean fever (FMF) patients. The study found that the level of miR-197-3p was dysregulated in the serum EVs of FMF patients, suggesting its potential as a diagnostic and therapeutic target.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
(2023)
Article
Rheumatology
Y. Endo, S-Y Kawashiri, A. Nishino, T. Michitsuji, T. Tomokawa, S. Nishihata, M. Okamoto, Y. Tsuji, S. Tsuji, T. Shimizu, R. Sumiyoshi, T. Igawa, T. Koga, N. Iwamoto, K. Ichinose, M. Tamai, H. Nakamura, T. Origuchi, Y. Ueki, T. Yoshitama, N. Eiraku, N. Matsuoka, A. Okada, K. Fujikawa, H. Otsubo, H. Takaoka, H. Hamada, T. Tsuru, M. Nawata, Y. Arinobu, T. Hidaka, Y. Tada, A. Kawakami
Summary: The study investigated the effectiveness of treatment with JAK inhibitors in rheumatoid arthritis patients, assessed by ultrasonography activity, and the impact of patient characteristics and previous treatments. The results showed that JAK inhibitors in combination with methotrexate and an absence of inadequate response to previous treatments demonstrated superior effectiveness for patients with RA, as indicated by improvement in clinical disease activity and US activity at 6 months compared with baseline.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
(2022)
Article
Immunology
Tomohiro Koga, Kunihiro Ichinose, George C. Tsokos
Summary: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs. Immune abnormalities contribute to the expression of the disease, with elements of the immune system instigating cellular damage. Correcting immune aberrations and preventing organ damage are both important.
CLINICAL IMMUNOLOGY
(2022)
Article
Medicine, General & Internal
Kazusato Hara, Masataka Umeda, Keiko Segawa, Midori Akagi, Yushiro Endo, Tomohiro Koga, Shin-Ya Kawashiri, Kunihiro Ichinose, Hideki Nakamura, Takahiro Maeda, Atsushi Kawakami
Summary: This article reports a case of a Japanese male patient with giant cell arteritis and atypical Cogan's syndrome. The patient achieved significant improvement after receiving tocilizumab treatment following an inadequate response to oral prednisolone.
Article
Medicine, General & Internal
Yutaka Tsukamoto, Masataka Umeda, Yuko Muto, Takashi Sugimoto, Momoko Yamauchi, Koji Ando, Koya Ariyoshi
Summary: This case report describes the first Asian case of secondary cold agglutinin syndrome (CAS) secondary to COVID-19. The patient also had monoclonal gammopathy of undetermined significance (MGUS). Corticosteroid therapy was effective in treating the anemia, suggesting its potential efficacy in CAS secondary to COVID-19 complicated with MGUS.
Article
Rheumatology
Ryo Hisada, Nobuya Yoshida, Seo Yeon K. Orite, Masataka Umeda, Catalina Burbano, Marc Scherlinger, Michihito Kono, Suzanne Krishfield, George C. Tsokos
Summary: The study revealed the crucial role of GLS2 in IL-2 production by CD4+ T cells, as well as its involvement in supporting antioxidant defense. These findings offer a new approach to correcting IL-2 production by T cells in SLE.
ARTHRITIS & RHEUMATOLOGY
(2022)
Article
Immunology
Yuya Fujita, Shoichi Fukui, Masataka Umeda, Sosuke Tsuji, Naoki Iwamoto, Yoshikazu Nakashima, Yoshiro Horai, Takahisa Suzuki, Akitomo Okada, Toshiyuki Aramaki, Yukitaka Ueki, Akinari Mizokami, Tomoki Origuchi, Hiroshi Watanabe, Kiyoshi Migita, Atsushi Kawakami
Summary: Patients with hypocomplementemia in IgG4-related disease (IgG4-RD) exhibit a more active clinical phenotype, suggesting the involvement of the complement system in the pathophysiology of IgG4-RD.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Shunsuke Mori, Akitomo Okada, Tomohiro Koga, Yukitaka Ueki
Summary: Discontinuation of bDMARDs/tofacitinib may be a feasible strategy in patients with rheumatoid arthritis, especially those with early treated and longer-controlled RA. Flares are manageable in most patients and radiological progression is rare for at least 3 years after discontinuation of bDMARDs/tofacitinib.
Article
Biochemistry & Molecular Biology
Yuki Uchida, Yuko Nariai, Eiji Obayashi, Yoshitsugu Tajima, Tomohiro Koga, Atsushi Kawakami, Takeshi Urano, Hiroki Kamino
Summary: In this study, novel anti-mouse IL-18 neoepitope antibodies were generated and a method to evaluate the activity of mouse IL-18 was established. The therapeutic efficacy of the anti-mouse IL-18 neoepitope antibodies was demonstrated in mouse models, providing proof-of-concept for their potential application in human inflammatory diseases.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
(2022)
Article
Medicine, General & Internal
Shin-Ya Nishihata, Toshimasa Shimizu, Masataka Umeda, Kaori Furukawa, Kaname Ohyama, Atsushi Kawakami, Hideki Nakamura
Summary: This study aimed to investigate the effect of toll-like receptor (TLR) 7 stimulation on the antigen presentation of tripartite motif-containing protein 21 (TRIM21) or Ro52/SS-A through major histocompatibility complex (MHC) class I in salivary gland epithelial cells (SGECs) from patients with Sjogren's syndrome (SS). SGECs from SS patients were stimulated with TLR7 agonist loxoribine and interferon-β. Increased MHC class I expression and enhanced Ro52 expression were observed in TLR7-stimulated SGECs, indicating the advancement of antigen presentation in SS patients' SGECs.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Rheumatology
Masataka Umeda, Hiroaki Kawano, Yushiro Endo, Ayuko Takatani, Tomohiro Koga, Kunihiro Ichinose, Hideki Nakamura, Akihiro Mukaino, Osamu Higuchi, Shunya Nakane, Takahiro Maeda, Atsushi Kawakami
Summary: This article describes three cases of severe autonomic disorders in systemic lupus erythematosus (SLE) patients, as demonstrated by the head-up tilt table test (HUT). These patients were treated with intensive immunosuppressive therapy, which resulted in negative HUT results, suggesting that this treatment may be effective for severe autonomic disorders in SLE patients. HUT is a useful objective method for diagnosing and evaluating the therapeutic effects of autonomic disorders in SLE patients with orthostatic intolerance.
MODERN RHEUMATOLOGY CASE REPORTS
(2022)
Article
Immunology
Tomoki Origuchi, Masataka Umeda, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Toshiaki Tsukada, Taiichiro Miyashita, Nozomi Iwanaga, Yoshiro Horai, Kazuhiko Arima, Toshiyuki Aramaki, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Summary: This study compared the complications during a 1-year follow-up in corticosteroid-treated RS3PE patients and EORA patients. While there was no significant increase in cardiovascular diseases, infections were significantly higher in RS3PE patients, with the initial corticosteroid dose being a risk factor for infections.
IMMUNOLOGICAL MEDICINE
(2022)